Accelerate Diagnostics, Inc. (AXDX)
USD 0.64
(-7.51%)
USD 0.64
(-7.51%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.31 Million USD | -36.27% |
| 2022 | 5.19 Million USD | 2.51% |
| 2021 | 5.06 Million USD | -45.02% |
| 2020 | 9.21 Million USD | 14.36% |
| 2019 | 8.05 Million USD | 4.04% |
| 2018 | 7.74 Million USD | -3.93% |
| 2017 | 8.06 Million USD | 1622.86% |
| 2016 | 468 Thousand USD | -71.43% |
| 2015 | 1.63 Million USD | 163799900.0% |
| 2014 | 1.00 USD | 0.0% |
| 2013 | 1.00 USD | -99.99% |
| 2012 | 10.26 Thousand USD | -66.1% |
| 2011 | 30.27 Thousand USD | -7.18% |
| 2010 | 32.62 Thousand USD | -38.97% |
| 2009 | 53.44 Thousand USD | -45.05% |
| 2008 | 97.26 Thousand USD | -9.82% |
| 2007 | 107.85 Thousand USD | 316.64% |
| 2006 | 25.88 Thousand USD | -4.98% |
| 2005 | 27.24 Thousand USD | -10.05% |
| 2004 | 30.28 Thousand USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 3.22 Million USD | -0.8% |
| 2024 Q1 | 3.24 Million USD | -1.84% |
| 2023 FY | 3.31 Million USD | -36.27% |
| 2023 Q1 | 5.27 Million USD | 1.46% |
| 2023 Q2 | 5.1 Million USD | -3.11% |
| 2023 Q4 | 3.31 Million USD | -6.84% |
| 2023 Q3 | 3.55 Million USD | -30.42% |
| 2022 Q1 | 5.5 Million USD | 8.64% |
| 2022 FY | 5.19 Million USD | 2.51% |
| 2022 Q4 | 5.19 Million USD | -3.67% |
| 2022 Q3 | 5.39 Million USD | 1.66% |
| 2022 Q2 | 5.3 Million USD | -3.65% |
| 2021 Q3 | 9.73 Million USD | 1.67% |
| 2021 Q4 | 5.06 Million USD | -47.93% |
| 2021 FY | 5.06 Million USD | -45.02% |
| 2021 Q1 | 9.78 Million USD | 6.17% |
| 2021 Q2 | 9.57 Million USD | -2.18% |
| 2020 Q3 | 9.45 Million USD | 8.44% |
| 2020 Q4 | 9.21 Million USD | -2.57% |
| 2020 Q1 | 8.52 Million USD | 5.81% |
| 2020 FY | 9.21 Million USD | 14.36% |
| 2020 Q2 | 8.72 Million USD | 2.3% |
| 2019 Q2 | 8.29 Million USD | -3.5% |
| 2019 Q3 | 7.88 Million USD | -5.03% |
| 2019 FY | 8.05 Million USD | 4.04% |
| 2019 Q4 | 8.05 Million USD | 2.26% |
| 2019 Q1 | 8.59 Million USD | 11.01% |
| 2018 Q1 | 10.12 Million USD | 25.6% |
| 2018 FY | 7.74 Million USD | -3.93% |
| 2018 Q4 | 7.74 Million USD | -17.65% |
| 2018 Q3 | 9.4 Million USD | -16.89% |
| 2018 Q2 | 11.31 Million USD | 11.75% |
| 2017 Q1 | 4.35 Million USD | 830.98% |
| 2017 Q3 | 7.34 Million USD | 28.34% |
| 2017 Q4 | 8.06 Million USD | 9.84% |
| 2017 FY | 8.06 Million USD | 1622.86% |
| 2017 Q2 | 5.72 Million USD | 31.28% |
| 2016 Q2 | 1.56 Million USD | -32.35% |
| 2016 Q4 | 468 Thousand USD | -63.06% |
| 2016 Q3 | 1.26 Million USD | -18.99% |
| 2016 FY | 468 Thousand USD | -71.43% |
| 2016 Q1 | 2.31 Million USD | 41.15% |
| 2015 Q2 | 1.00 USD | -100.0% |
| 2015 Q1 | 473 Thousand USD | 47299900.0% |
| 2015 Q4 | 1.63 Million USD | 0.0% |
| 2015 FY | 1.63 Million USD | 163799900.0% |
| 2015 Q3 | - USD | -100.0% |
| 2014 FY | 1.00 USD | 0.0% |
| 2014 Q1 | 1.00 USD | 0.0% |
| 2014 Q3 | 1.00 USD | 0.0% |
| 2014 Q4 | 1.00 USD | 0.0% |
| 2014 Q2 | - USD | -100.0% |
| 2013 Q2 | - USD | -100.0% |
| 2013 Q3 | 1.00 USD | 0.0% |
| 2013 Q4 | 1.00 USD | 0.0% |
| 2013 FY | 1.00 USD | -99.99% |
| 2013 Q1 | - USD | -100.0% |
| 2012 Q1 | 30.27 Thousand USD | 0.0% |
| 2012 Q2 | 10.26 Thousand USD | -66.1% |
| 2012 Q3 | 30.27 Thousand USD | 195.02% |
| 2012 Q4 | 10.26 Thousand USD | -66.1% |
| 2012 FY | 10.26 Thousand USD | -66.1% |
| 2011 Q2 | 30.27 Thousand USD | -0.88% |
| 2011 FY | 30.27 Thousand USD | -7.18% |
| 2011 Q1 | 30.54 Thousand USD | -7.21% |
| 2011 Q3 | 30.27 Thousand USD | 0.0% |
| 2011 Q4 | 30.27 Thousand USD | 0.0% |
| 2010 Q1 | 34.34 Thousand USD | -4.72% |
| 2010 FY | 32.62 Thousand USD | -38.97% |
| 2010 Q4 | 32.92 Thousand USD | 0.0% |
| 2010 Q3 | 32.92 Thousand USD | 0.92% |
| 2010 Q2 | 32.62 Thousand USD | -5.02% |
| 2009 Q3 | 43.54 Thousand USD | -18.52% |
| 2009 FY | 53.44 Thousand USD | -45.05% |
| 2009 Q1 | 69.39 Thousand USD | -12.05% |
| 2009 Q2 | 53.44 Thousand USD | -22.98% |
| 2009 Q4 | 36.04 Thousand USD | -17.22% |
| 2008 Q4 | 78.9 Thousand USD | -18.88% |
| 2008 Q3 | 97.26 Thousand USD | 0.0% |
| 2008 Q1 | 98.86 Thousand USD | -1.2% |
| 2008 Q2 | 97.26 Thousand USD | -1.61% |
| 2008 FY | 97.26 Thousand USD | -9.82% |
| 2007 Q4 | 100.06 Thousand USD | -7.54% |
| 2007 Q2 | 107.85 Thousand USD | 270.25% |
| 2007 Q3 | 108.21 Thousand USD | 0.33% |
| 2007 Q1 | 29.13 Thousand USD | -0.62% |
| 2007 FY | 107.85 Thousand USD | 316.64% |
| 2006 Q4 | 29.31 Thousand USD | 28.86% |
| 2006 FY | 25.88 Thousand USD | -4.98% |
| 2006 Q3 | 22.74 Thousand USD | -12.13% |
| 2006 Q2 | 25.88 Thousand USD | 3.41% |
| 2006 Q1 | 25.03 Thousand USD | -2.27% |
| 2005 Q3 | 27.24 Thousand USD | 0.0% |
| 2005 Q4 | 25.61 Thousand USD | -5.98% |
| 2005 Q1 | 24.09 Thousand USD | -26.53% |
| 2005 FY | 27.24 Thousand USD | -10.05% |
| 2005 Q2 | 27.24 Thousand USD | 13.05% |
| 2004 Q1 | 63.3 Thousand USD | -7.66% |
| 2004 FY | 30.28 Thousand USD | 0.0% |
| 2004 Q4 | 32.79 Thousand USD | 26.53% |
| 2004 Q2 | 30.28 Thousand USD | -52.16% |
| 2004 Q3 | 25.92 Thousand USD | -14.42% |
| 2003 Q4 | 68.55 Thousand USD | -0.63% |
| 2003 FY | - USD | 0.0% |
| 2003 Q3 | 68.99 Thousand USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | -100.0% |
| 2002 Q4 | 96.33 Thousand USD | 137.2% |
| 2002 FY | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | 40.61 Thousand USD | 0.0% |
| 2001 Q2 | 2625.00 USD | -25.0% |
| 2001 Q4 | - USD | -100.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q3 | 1750.00 USD | -33.33% |
| 2001 Q1 | 3500.00 USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q4 | 3500.00 USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| BrainsWay Ltd. | 3.71 Million USD | 10.95% |
| Cerus Corporation | 39.86 Million USD | 91.698% |
| Envoy Medical, Inc. | 1.4 Million USD | -135.755% |
| electroCore, Inc. | 2.16 Million USD | -53.241% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -624.289% |
| IceCure Medical Ltd | 2.27 Million USD | -45.495% |
| Inogen, Inc. | 21.84 Million USD | 84.844% |
| OrthoPediatrics Corp. | 105.85 Million USD | 96.873% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -1090.647% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -330999900.0% |
| MaxCyte, Inc. | 12.22 Million USD | 72.933% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -91.697% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -2016.098% |
| Orthofix Medical Inc. | 222.16 Million USD | 98.51% |
| PAVmed Inc | 1.01 Million USD | -225.467% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 83.418% |
| RxSight, Inc. | 17.42 Million USD | 81.0% |
| Sight Sciences, Inc. | 7.84 Million USD | 57.829% |
| SI-BONE, Inc. | 20.24 Million USD | 83.654% |
| TELA Bio, Inc. | 13.16 Million USD | 74.852% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 88.682% |
| Vivos Therapeutics, Inc. | 1.00 USD | -330999900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | 22.627% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -1339.13% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -40.492% |
| CVRx, Inc. | 10.98 Million USD | 69.863% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -748.553% |
| Bioventus Inc. | 91.33 Million USD | 96.376% |
| Venus Concept Inc. | 28.67 Million USD | 88.457% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -30.059% |
| LivaNova PLC | 147.88 Million USD | 97.762% |
| 908 Devices Inc. | 14.93 Million USD | 77.842% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 97.581% |
| Nemaura Medical Inc. | 1.75 Million USD | -88.62% |
| NeuroPace, Inc. | 11.21 Million USD | 70.483% |
| LENSAR, Inc. | 15.68 Million USD | 78.902% |
| Apyx Medical Corporation | 9.92 Million USD | 66.643% |
| Cutera, Inc. | 72.1 Million USD | 95.409% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -23.831% |
| BioSig Technologies, Inc. | -103 Thousand USD | 3313.592% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 92.864% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | 58.16% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 99.15% |
| Axonics, Inc. | 79.94 Million USD | 95.859% |
| Outset Medical, Inc. | 49.21 Million USD | 93.274% |
| IRIDEX Corporation | 9.9 Million USD | 66.586% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 91.674% |
| IRadimed Corporation | 12.82 Million USD | 74.183% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -337.831% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -1151.385% |
| Telesis Bio, Inc. | 4.02 Million USD | 17.764% |
| Viemed Healthcare, Inc. | 4.6 Million USD | 28.111% |
| Varex Imaging Corporation | 277.5 Million USD | 98.807% |
| Quipt Home Medical Corp. | 18.32 Million USD | 81.938% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | 80.231% |
| Dynatronics Corporation | 5.59 Million USD | 40.829% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | 11.521% |
| Semler Scientific, Inc. | 445 Thousand USD | -643.82% |
| InMode Ltd. | 45.09 Million USD | 92.66% |
| Bruker Corporation | 968.3 Million USD | 99.658% |
| Cytosorbents Corporation | 3.68 Million USD | 10.058% |
| DexCom, Inc. | 559.6 Million USD | 99.409% |
| Align Technology, Inc. | 296.9 Million USD | 98.885% |
| Viveve Medical, Inc. | 1.47 Million USD | -124.864% |
| ZimVie Inc. | 79.6 Million USD | 95.842% |
| Movano Inc. | 1.51 Million USD | -118.771% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 94.563% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -2016.098% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 97.904% |
| Profound Medical Corp. | 6.95 Million USD | 52.396% |
| Insulet Corporation | 402.6 Million USD | 99.178% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | 77.694% |
| iCAD, Inc. | 917 Thousand USD | -260.96% |
| Nuwellis, Inc. | 1.99 Million USD | -65.749% |
| Biotricity, Inc. | 1.87 Million USD | -76.12% |
| iRhythm Technologies, Inc. | 13.97 Million USD | 76.311% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -57.17% |
| PAVmed Inc. | 1.01 Million USD | -225.467% |
| BIOLASE, Inc. | 11.43 Million USD | 71.049% |
| Beyond Air, Inc. | 2.12 Million USD | -55.618% |
| FONAR Corporation | 2.71 Million USD | -21.895% |
| AxoGen, Inc. | 23.02 Million USD | 85.621% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 85.307% |
| Inari Medical, Inc. | 42.9 Million USD | 92.284% |
| UFP Technologies, Inc. | 70.19 Million USD | 95.284% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -426.082% |
| Tenon Medical, Inc. | 554 Thousand USD | -497.473% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -98.832% |
| AdaptHealth Corp. | 113.64 Million USD | 97.087% |
| Sintx Technologies, Inc. | 888 Thousand USD | -272.748% |
| NanoVibronix, Inc. | 2.73 Million USD | -21.157% |
| Quanterix Corporation | 22.36 Million USD | 85.2% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 77.706% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 94.16% |
| TransMedics Group, Inc. | 44.23 Million USD | 92.517% |
| ReWalk Robotics Ltd. | 5.65 Million USD | 41.447% |
| NeuroMetrix, Inc. | 1.55 Million USD | -112.257% |
| Hyperfine, Inc. | 6.58 Million USD | 49.711% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 95.859% |
| Biomerica, Inc. | 2.37 Million USD | -39.31% |
| Bone Biologics Corporation | -328.84 Thousand USD | 1106.556% |
| AVITA Medical, Inc. | 3.12 Million USD | -6.042% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 88.921% |